{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cullinan Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"CGEM"},"Address":{"label":"Address","value":"ONE MAIN STREET,SUITE 520, CAMBRIDGE, Massachusetts, 02142, United States"},"Phone":{"label":"Phone","value":"+1 617 410-4650"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients."},"CompanyUrl":{"label":"Company Url","value":"https://cullinantherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jeffrey Jones","title":"Chief Medical Officer"},{"name":"Jennifer Michaelson","title":"Chief Scientific Officer"},{"name":"Kevin A. Johnston","title":"Chief Technical Operations Officer"},{"name":"Nadim Ahmed","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}